John J. Kirby insider trades: Verrica Pharmaceuticals (VRCA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | VRCA | ↑ Buy | 3,536 | $4.24 | $15K | Direct | Nov 25, 2025 (0d) |
| Dec 17, 2021 | IDRA | ↑ Buy | 10,000 | $0.61 | $6K | Direct | Dec 21, 2021 (4d) |
| Mar 25, 2021 | IDRA | ↓ Sell | 6,250 | $1.42 | $9K | Direct | Mar 29, 2021 (4d) |
| Jan 12, 2021 | IDRA | ↓ Sell | 1,693 | $4.22 | $7K | Direct | Jan 12, 2021 (0d) |
| Jan 5, 2021 | IDRA | ↓ Sell | 862 | $3.90 | $3K | Direct | Jan 6, 2021 (1d) |
| Jan 7, 2020 | IDRA | ↓ Sell | 911 | $1.78 | $2K | Direct | Jan 10, 2020 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other VRCA insiders
Open-market trades in the last 12 months
About John J. Kirby's insider trades
John J. Kirby is Interim CFO at Verrica Pharmaceuticals (VRCA). Since Jan 7, 2020, John has reported 2 open-market purchases worth $21K and 4 sales worth $21K on SEC Form 4. In the last 12 months: 1 buy ($15K).
Their filings also include grants and awards (16 filings), other transactions (2 filings), shares withheld for taxes (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VRCA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.